Stock listing

NASDAQ:HCTI Healthcare Triangle, Inc. Stock

Home listing (NASDAQ) of Healthcare Triangle, Inc.

Follow Healthcare Triangle, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:HCTI

$2.88 USD -0.29 (-9.0%)

Close on Nov 20, 2026

Past year -99.9% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$2.86 – $2.96 USDNov 20, 2026
Volume
7,921 sharesNov 20, 2026
Market cap
$2.63M USDAt the close on Nov 20, 2026 · price × 915,189 shares outstanding
52-week range
$2.86 – $3,096.00 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$203,744 USDMedian day 882 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Healthcare Triangle, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:HCTI · Home$2.875 USD-0.285 (-9.0%)7,921$2.902$2.964$2.86$3.16Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:HCTI · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$2.875-0.285-9.0%$2.902$2.964$2.867,921
$3.16-0.22-6.5%$3.29$3.295$3.119,472
$3.38+0.05+1.5%$3.46$3.54$3.2622,078
$3.33-0.33-9.0%$3.60$3.60$3.31413,183
$3.66-0.08-2.1%$4.00$4.00$3.50819,087
$3.74-0.65-14.8%$4.70$4.818$3.7494,035
$4.39+0.18+4.3%$4.29$4.48$4.25118,688
$4.21-0.01-0.2%$4.31$4.38$4.0018,488
$4.22+0.52+14.1%$3.98$4.37$3.6361,535
$3.70+0.11+3.1%$3.71$3.80$3.6510,662
$3.59-1.03-22.3%$4.45$4.45$3.5156,678
$4.62-0.62-11.8%$5.13$5.13$4.535108,522
$5.24+0.26+5.2%$5.46$7.43$4.98999,585
$4.98-0.16-3.1%$5.33$5.51$4.55290,980
$5.14-1.16-18.4%$6.17$6.17$5.1411,900
$6.30-0.13-2.0%$6.40$6.73$6.29618,500
$6.43-0.37-5.4%$6.74$6.87$6.27618,500
$6.80-0.04-0.6%$6.98$7.13$6.5827,200
$6.84+0.12+1.8%$6.85$7.40$6.1551,600
$6.72-0.86-11.3%$7.66$7.66$6.62823
$7.58-0.72-8.7%$7.98$8.16$7.40678
$8.30+0.42+5.3%$8.30$8.34$7.86379
$7.88+0.60+8.2%$7.70$8.00$7.242,109
$7.28-0.68-8.5%$8.08$8.08$7.20350
$7.96-0.38-4.6%$8.46$8.66$7.72254
$8.34+0.70+9.2%$7.42$8.36$7.42385
$7.64-0.72-8.6%$8.28$8.64$7.60629
$8.36-0.28-3.2%$8.68$8.68$8.20460
$8.64-1.02-10.6%$9.66$9.88$8.28667
$9.66-0.44-4.4%$10.04$10.20$9.10688
$10.10-1.18-10.5%$11.16$11.16$10.10584
$11.28+0.16+1.4%$10.78$11.74$10.00711
$11.12-1.02-8.4%$11.90$11.90$11.06882
$12.14-2.36-16.3%$12.00$12.14$11.602,312
$14.50+0.46+3.3%$14.70$14.70$13.801,862
$14.04-0.32-2.2%$14.00$14.44$13.622,155
$14.36+1.12+8.5%$13.12$18.60$13.0061,871
$13.24-1.76-11.7%$14.58$14.96$13.141,543
$15.00-0.56-3.6%$15.00$15.80$14.201,183
$15.56+0.96+6.6%$14.96$15.80$14.063,190
$14.60-3.62-19.9%$15.78$15.80$13.006,729
$18.22+0.92+5.3%$22.20$63.00$17.80136,039
$17.30+1.70+10.9%$15.90$17.40$15.60371
$15.60+0.10+0.6%$15.52$16.90$15.40370
$15.50+1.30+9.2%$14.58$16.00$14.40869
$14.20+0.40+2.9%$14.60$15.00$13.60287
$13.80-0.40-2.8%$14.40$14.74$13.64225
$14.20-0.66-4.4%$15.38$15.38$14.20129
$14.86-0.06-0.4%$14.66$15.40$14.40102
$14.92+0.04+0.3%$15.30$15.54$14.80131
$14.88-0.12-0.8%$15.00$15.60$14.50180
$15.00-0.76-4.8%$16.14$16.14$14.50497
$15.76-0.06-0.4%$16.02$16.02$15.40474
$15.82-1.34-7.8%$17.34$17.34$15.421,036
$17.16+0.76+4.6%$17.88$20.20$16.805,670
$16.40+0.20+1.2%$16.50$16.66$16.16124
$16.20-0.30-1.8%$16.46$16.80$16.02348
$16.50-0.38-2.3%$17.20$17.20$16.44145
$16.88+0.12+0.7%$17.00$17.78$16.60266
$16.76-0.60-3.5%$17.80$17.80$16.50418
$17.36+0.68+4.1%$16.76$17.40$16.76296
$16.68-0.22-1.3%$17.00$17.10$16.60357
$16.90-0.68-3.9%$17.78$17.80$16.50584
$17.58-1.22-6.5%$18.60$19.54$17.26777
$18.80-0.70-3.6%$20.00$20.00$18.40971

Splits

4 splits since 2023 · NASDAQ:HCTI · every price before a split is adjusted for it

DayRatioWhat
1-for-20Consolidation
1-for-60Consolidation
1-for-249Consolidation
1-for-10Consolidation
Ticker
NASDAQ:HCTI
Asset type
Stock
Sector
Health care
Industry
Health care services
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Healthcare Triangle, Inc. news

Healthcare Triangle, Inc. on 6ix

Sector
Health care
Industry
Health care services
News releases
30 in the last 12 months · 119 in all · newest Nov 12, 2026 · oldest 2021
Decks
4 decks · latest Sep 15, 2025

Where Healthcare Triangle, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:HCTI · Home listing · This pageNASDAQUnited StatesUSD
BOATS:HCTIBOATSUnited StatesUSD
Stuttgart:4MR0StuttgartGermanyEUR

Valuation

EV/sales 0.6× against a median of 2.2×: 2nd lowest of 9 Health care services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$17.54M USD
P/E
Loss
EV/sales
0.6×
EV/EBITDA
Negative EBITDA
Price/book
0.1×
Gross margin
541.8%
Operating margin
−45.2%
Net margin
−56.4%
Debt to equity
0.3×
Beta vs S&P 500
2.08

Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Healthcare Triangle, Inc. · NASDAQ:HCTIUS$2.63MUS$17.54Mn/a0.6×n/a0.1×−56.4%0.3×2.08
Basel Medical Group Ltd · NASDAQ:BMGLUS$2.91MUS$9.95Mn/a0.6×1.1×0.7×−3.5%1.9×0.58
Polomar Health Services, Inc. · OTC:PMHSUS$2.84MUS$2.58Mn/an/an/an/an/an/a0.25
Mangoceuticals, Inc. · NASDAQ:MGRXUS$2.75MUS$2.73Mn/a9.1×n/a0.3×n/a0.1×0.60
UniDoc Health Corp. · CSE:UDOCUS$2.71MUS$2.66Mn/a4.0×n/an/a−327.1%n/a-0.61
Modern Mobility Aids, Inc. · OTC:MDRMUS$2.68MUS$2.71Mn/an/an/an/an/an/a-0.74
Monsenso A/S · OMXCOP:MONSOUS$2.57MUS$2.69Mn/a2.1×n/a2.6×−81.0%0.1×n/a
Visionflex Group Limited · ASX:VFXUS$2.30MUS$1.61Mn/a0.6×n/an/a−1.4%n/an/a
Imaging Biometrics Limited · LSE:IBAIUS$2.26MUS$2.43Mn/a2.4×n/a5.6×−50.9%0.6×n/a
Feedback plc · LSE:FDBKUS$2.24M−US$2.77Mn/a−2.4×n/a0.4×−826.2%0.0×n/a
Predilife SA · EURONEXT:ALPREUS$2.16MUS$7.61Mn/a6.2×n/an/a−315.3%n/an/a
Median of the othersUS$2.63MUS$2.67M2.2×1.1×0.7×−81.0%0.1×0.25

Forecasts

Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.

Price target
63.00 USD · Analysts' mean
EPS, year to Dec 2026
-204.60 · 1 analyst
Revenue, year to Dec 2026
38.84M · 1 analyst

Team and board

OfficerRole
Melissa HallChief Nursing Officer

Events

QuarterResultsShare move
Q3 2026Nov 13, 2026−11.0%
Q2 2026Aug 13, 2026 · After close−30.1%
Q1 2026Apr 15, 2026 · After close−3.2%
Q3 2025Nov 13, 2025 · Before open−16.1%
Q2 2025Aug 14, 2025+23.1%
Q1 2025May 20, 2025−11.1%
Q4 2024Mar 31, 2025−5.2%
Q3 2024Nov 29, 2024−5.9%
Q2 2024Aug 7, 2024−23.1%
Q1 2024May 20, 2024 · After close+9.9%
All 20 quarters
QuarterResultsShare move
Q4 2023Mar 18, 2024 · After close+4.2%
Q3 2023Nov 13, 2023 · Before open0.0%
Q2 2023Aug 10, 2023 · After close0.0%
Q1 2023May 9, 2023 · Before open+3.7%
Q4 2022Mar 28, 2023 · After close0.0%
Q3 2022Nov 10, 2022 · Before open−5.1%
Q2 2022Aug 8, 2022 · Before open0.0%
Q1 2022May 16, 2022 · Before open0.0%
Q4 2021Mar 8, 2022 · After close0.0%
Quarter to Sep 30, 2021Oct 14, 20210.0%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (September 2025)Investor deck9 slidesSep 15, 2025
Investor Presentation (March 2022)Investor deck25 slidesMar 7, 2022
IPO Roadshow (September 2021)IPO roadshow34 slidesSep 9, 2021
IPO Roadshow (September 2021)IPO roadshow33 slidesSep 8, 2021

Open Decks

Financings

RaiseDate
15% original issue discount senior convertible promissory notes
Closed: US$3.6M raised · WallachBeth Capital LLC
Dealers: WallachBeth Capital LLC (lead)
Use of proceeds: Repayment of certain prior indebtedness, potential strategic acquisitions, and general working capital
Jun 12, 2026
Registered direct offering of common stock (or prefunded warrants in lieu thereof)
Announced: about US$3.96M · US$5.81 a share · D. Boral Capital, LLC
Dealers: D. Boral Capital, LLC (lead)
Feb 26, 2026
Warrant exercise of existing warrants exercised for common stock; new unregistered warrants
Announced: about US$478,000 · US$2 a share · Warrants at US$3 for 60 months · WallachBeth Capital
Dealers: WallachBeth Capital
Oct 8, 2025
Warrant exercise of existing warrants exercised for common stock; new unregistered warrants
Announced: about US$755,000 · US$2 a share · Warrants at US$3 for 60 months · WallachBeth Capital
Dealers: WallachBeth Capital
Oct 3, 2025
Warrant exercise of existing warrants exercised for common stock; new unregistered warrants
Announced: about US$1.63M · US$2 a share · Warrants at US$3 for 60 months · WallachBeth Capital
Dealers: WallachBeth Capital (lead)
Oct 2, 2025
Private placement of units of common stock or pre-funded warrants with series A and series B warrants
Closed: US$15.2M raised · US$0.42 a unit · Warrants at US$0.84 · RBW Capital, LLC (a division of Dawson James Securities, Inc) +2
Dealers: RBW Capital, LLC (a division of Dawson James Securities, Inc) (co-lead), Spartan Capital Securities, LLC (co-lead), RBW Capital Partners LLC (a division of Dawson James Securities, Inc.) (co-lead)
Use of proceeds: Future acquisitions, general corporate purposes and working capital
Feb 28, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$4.00 a share on Oct 12, 2021.

Price
US$4.00 a share
Shares offered
4,709,255 shares of common stock · 3,262,500 from the company and 1,446,755 from selling shareholders
Offering size
US$18.8 million · Shares offered times the price, worked out by 6ix
Underwriters' option
Up to 489,375 more shares
Listing
HCTI on the Nasdaq Capital Market
Underwriter
EF HUTTON

Steps

StepWhen
Draft sent to the SEC in confidenceApr 19, 2021
Filed publiclyAug 30, 2021
Amended 5 timesNewest Oct 8, 2021
Shares registered with an exchangeOct 12, 2021
Declared effective by the SECOct 12, 2021
Final prospectus, with the priceOct 14, 2021

Open IPO · From the cover of the final prospectus (424B4) filed Oct 14, 2021

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2016FY2015FY2014
Revenue13.9M11.7M33.2M45.9M35.3M31.3M28.7M232.4K5.82K29.4K
Cost of revenue12.0M8.81M26.4M34.6M24.7M22.8M23.7M134.3K4.61K1.99K
Gross profit1.24B1.07B1.07B11.3M10.5M7.78M5.07M98.0K1.21K27.4K
Research and development536.0K429.0K799.0K8.14M5.26M1.74M1.01M000
Selling, general and administrative7.34M3.95M5.73M002.44M1.70M1.07M1.87M2.95M
Operating income-9.79M-4.75M-7.70M-16.3M-5.36M1.18M1.67M-1.29M-2.98M-3.73M
Depreciation and amortization705.0K889.0K1.57M2.94M1.42M803.2K776.1K705.5K1.11M808.7K
EBITDA-9.08M-3.86M-6.13M-13.4M-3.94M1.98M2.45M-583.0K-1.87M-2.92M
Interest expense567.0K1.21M968.0K212.0K567.0K78.6K52.6K000
Income before tax-9.48M-5.96M-8.65M-13.9M-5.92M2.61M1.62M-4.58M-6.73M-5.83M
Income tax12.0K35.0K506.0K24.0K257.4K444.4K000
Net income-9.48M-5.97M-8.69M-14.4M-5.95M2.35M1.17M-4.58M-6.73M-5.83M
Earnings per share, basic-152.30-16,909.30-2.08-3.88-0.200.08-323.99-476.38-412.90
Earnings per share, diluted-152.30-16,909.30-2.08-3.88-0.200.08

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2016FY2015FY2014
Cash and equivalents7.63M20.0K1.23M1.34M1.77M1.40M974.8K2823.9K0
Short-term investments000
Receivables2.07M1.11M3.60M5.87M9.67M6.40M4.17M
Inventory11000
Current assets13.2M1.45M5.65M8.02M11.8M8.03M5.29M2823.9K0
Property, plant and equipment5.00K12.0K44.0K80.0K74.0K15.8K41.6K000
Goodwill2.95M01.29M1.29M1.29M0000
Total assets22.7M1.96M6.86M13.3M24.6M11.1M8.25M2.12M1.17M2.14M
Accounts payable744.0K2.54M1.95M1.48M1.87M4.35M5.10M1.17M866.1K667.3K
Current liabilities12.8M7.08M8.15M6.60M6.25M6.78M6.20M9.88M6.49M6.19M
Long-term debt888.0K01.34M1.34M
Total debt10.7M2.65M4.68M2.69M3.45M754.4K
Total liabilities12.8M7.08M8.25M7.22M8.48M6.78M6.28M9.88M7.83M7.71M
Shareholders' equity9.98M-5.11M538.0K6.04M14.2M4.33M1.97M-7.75M-6.66M-5.58M
Shares outstanding7.12K3804.31M4.17M35.3M27.9M1214.1K14.1K14.1K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2016FY2015FY2014
Cash from operations-16.5M-1.08M-2.15M-5.35M-7.11M-734.7K3.97M-971.3K-513.6K-394.1K
Capital spending-6.00K-13.0K-12.0K-40.0K-3.13M-3-3.65M-5.00K00
Free cash flow-16.5M-1.08M-2.16M-5.39M-10.2M-734.7K3.97M-976.3K-513.6K-394.1K
Cash from investing-1.75M-13.0K-12.0K-1.13M-7.63M-477.5K-3.65M-5.00K-12.0K-12.0K
Cash from financing25.9M-133.0K2.06M6.06M15.1M1.64M1.64M952.5K549.5K394.1K
Dividends paid00000
Share buybacks-142.0K-141.0K0696696
Change in cash7.61M-1.21M-107.0K-429.0K367.0K427.9K974.8K-23.9K23.9K23.9K

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 13, 2026Quarterly reportSEC
8-K · Current reportOct 27, 2026Current reportSEC
8-K · Current reportOct 23, 2026Meeting outcomeSEC
DEF 14A · Proxy statementOct 13, 2026Meeting noticeSEC
PRE 14A · Preliminary proxy statementOct 2, 2026Meeting noticeSEC
8-K · Current reportOct 2, 2026Current reportSEC
EFFECT · Notice that a registration is effectiveOct 1, 2026Other filingsSEC
POS AM · Amendment to an effective registrationSep 25, 2026Offer documentSEC
8-K · Current reportSep 25, 2026Material contractSEC
8-K · Current reportSep 8, 2026Material contractSEC
Show 200 filings
FilingDateTypeFiled with
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
8-K · Current reportJul 29, 2026FinancingSEC
8-K · Current reportJul 20, 2026Meeting outcomeSEC
424B3 · ProspectusJul 16, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveJul 16, 2026Other filingsSEC
S-1 · Registration statementJul 10, 2026Offer documentSEC
RW · Request to withdraw a registrationJul 9, 2026Other filingsSEC
S-3 · Registration statementJul 6, 2026Offer documentSEC
DEF 14A · Proxy statementJun 26, 2026Meeting noticeSEC
8-K · Current reportJun 26, 2026Material contractSEC
PRE 14A · Preliminary proxy statementJun 16, 2026Meeting noticeSEC
DJun 16, 2026Other filingsSEC
8-K · Current reportJun 15, 2026Material contractSEC
10-Q · Quarterly reportMay 13, 2026Quarterly reportSEC
10-K/A · Annual report, amendedApr 16, 2026Annual reportSEC
10-K · Annual reportApr 15, 2026Annual reportSEC
8-K · Current reportApr 10, 2026Material contractSEC
8-K/A · Current report, amendedApr 7, 2026Current reportSEC
NT 10-K · Late filing noticeMar 31, 2026Explanation requestSEC
424B5 · ProspectusMar 31, 2026Offer documentSEC
8-K · Current reportMar 11, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 5, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeMar 2, 2026Big-stake noticeSEC
8-K · Current reportFeb 27, 2026Material contractSEC
424B5 · ProspectusFeb 27, 2026Offer documentSEC
8-K · Current reportFeb 13, 2026Current reportSEC
8-K · Current reportFeb 6, 2026Meeting outcomeSEC
8-K · Current reportJan 28, 2026Acquisition or disposalSEC
DEF 14A · Proxy statementJan 20, 2026Meeting noticeSEC
PRE 14A · Preliminary proxy statementJan 9, 2026Meeting noticeSEC
EFFECT · Notice that a registration is effectiveDec 22, 2025Other filingsSEC
CORRESP · Letter to the SECDec 16, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedDec 15, 2025Big-stake noticeSEC
8-K · Current reportDec 10, 2025Material contractSEC
DDec 3, 2025Other filingsSEC
8-K · Current reportDec 2, 2025Meeting outcomeSEC
S-3 · Registration statementNov 28, 2025Offer documentSEC
424B3 · ProspectusNov 25, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveNov 25, 2025Other filingsSEC
8-K · Current reportNov 21, 2025Material contractSEC
CORRESP · Letter to the SECNov 20, 2025Other filingsSEC
S-3/A · Registration statement, amendedNov 19, 2025Offer documentSEC
8-K · Current reportNov 19, 2025Material contractSEC
424B5 · ProspectusNov 19, 2025Offer documentSEC
DEF 14A · Proxy statementNov 18, 2025Meeting noticeSEC
10-Q · Quarterly reportNov 13, 2025Quarterly reportSEC
8-K · Current reportNov 10, 2025Meeting outcomeSEC
PRE 14A · Preliminary proxy statementNov 7, 2025Meeting noticeSEC
S-3 · Registration statementOct 16, 2025Offer documentSEC
DEF 14A · Proxy statementOct 15, 2025Meeting noticeSEC
DEF 14COct 14, 2025Meeting noticeSEC
8-K · Current reportOct 8, 2025Material contractSEC
PRE 14COct 2, 2025Meeting noticeSEC
PRE 14A · Preliminary proxy statementSep 30, 2025Meeting noticeSEC
8-K · Current reportSep 15, 2025Current reportSEC
8-K/A · Current report, amendedAug 29, 2025Material contractSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
8-K · Current reportAug 1, 2025Current reportSEC
8-K · Current reportJul 7, 2025Current reportSEC
8-K · Current reportJun 23, 2025Acquisition or disposalSEC
8-K · Current reportMay 30, 2025Current reportSEC
8-K · Current reportMay 23, 2025Current reportSEC
10-Q · Quarterly reportMay 20, 2025Quarterly reportSEC
424B4 · ProspectusMay 15, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveMay 15, 2025Other filingsSEC
CORRESP · Letter to the SECMay 13, 2025Other filingsSEC
CORRESP · Letter to the SECMay 13, 2025Other filingsSEC
CORRESP · Letter to the SECMay 13, 2025Other filingsSEC
NT 10-Q · Late filing noticeMay 9, 2025Explanation requestSEC
CORRESP · Letter to the SECMay 8, 2025Other filingsSEC
S-1/A · Registration statement, amendedMay 8, 2025Offer documentSEC
UPLOAD · Letter from the SECMay 5, 2025Other filingsSEC
CORRESP · Letter to the SECApr 22, 2025Other filingsSEC
S-1/A · Registration statement, amendedApr 22, 2025Offer documentSEC
UPLOAD · Letter from the SECApr 15, 2025Other filingsSEC
8-K · Current reportApr 11, 2025Current reportSEC
8-K · Current reportApr 11, 2025Management or board changeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
8-K · Current reportApr 2, 2025Meeting outcomeSEC
S-1 · Registration statementApr 2, 2025Offer documentSEC
10-K · Annual reportMar 31, 2025Annual reportSEC
8-K · Current reportMar 24, 2025Management or board changeSEC
DEF 14CMar 17, 2025Meeting noticeSEC
SCHEDULE 13G · Big-stake noticeMar 7, 2025Big-stake noticeSEC
DEF 14A · Proxy statementMar 7, 2025Meeting noticeSEC
PRE 14CMar 5, 2025Meeting noticeSEC
8-K · Current reportFeb 28, 2025Material contractSEC
8-K · Current reportFeb 26, 2025Current reportSEC
PRE 14A · Preliminary proxy statementFeb 25, 2025Meeting noticeSEC
10-K/A · Annual report, amendedFeb 14, 2025Annual reportSEC
8-K · Current reportFeb 14, 2025Current reportSEC
SCHEDULE 13G · Big-stake noticeFeb 4, 2025Big-stake noticeSEC
8-K · Current reportJan 21, 2025Current reportSEC
8-K · Current reportDec 4, 2024Current reportSEC
8-K/A · Current report, amendedDec 2, 2024Material contractSEC
10-Q · Quarterly reportNov 14, 2024Quarterly reportSEC
8-K · Current reportOct 25, 2024Material contractSEC
8-K · Current reportSep 10, 2024Management or board changeSEC
8-K · Current reportSep 6, 2024Current reportSEC
PRE 14CAug 30, 2024Meeting noticeSEC
10-Q · Quarterly reportAug 19, 2024Quarterly reportSEC
NT 10-Q · Late filing noticeAug 15, 2024Explanation requestSEC
8-K · Current reportJun 27, 2024Current reportSEC
10-Q · Quarterly reportMay 20, 2024Quarterly reportSEC
NT 10-Q · Late filing noticeMay 16, 2024Explanation requestSEC
8-K · Current reportMay 13, 2024Current reportSEC
8-K · Current reportMay 6, 2024Current reportSEC
8-K · Current reportMar 22, 2024Current reportSEC
10-K · Annual reportMar 18, 2024Annual reportSEC
8-K · Current reportMar 18, 2024Management or board changeSEC
4 · Change in ownershipMar 13, 2024Insider tradeSEC
4 · Change in ownershipMar 13, 2024Insider tradeSEC
4 · Change in ownershipMar 13, 2024Insider tradeSEC
EFFECT · Notice that a registration is effectiveFeb 14, 2024Other filingsSEC
CORRESP · Letter to the SECFeb 13, 2024Other filingsSEC
S-1/A · Registration statement, amendedFeb 12, 2024Offer documentSEC
S-1/A · Registration statement, amendedFeb 9, 2024Offer documentSEC
CORRESP · Letter to the SECFeb 9, 2024Other filingsSEC
8-K · Current reportFeb 2, 2024Current reportSEC
8-K · Current reportFeb 1, 2024Management or board changeSEC
EFFECT · Notice that a registration is effectiveFeb 1, 2024Other filingsSEC
CORRESP · Letter to the SECJan 29, 2024Other filingsSEC
UPLOAD · Letter from the SECJan 26, 2024Other filingsSEC
DEF 14CJan 19, 2024Meeting noticeSEC
S-3/A · Registration statement, amendedJan 16, 2024Offer documentSEC
UPLOAD · Letter from the SECJan 16, 2024Other filingsSEC
S-1 · Registration statementJan 12, 2024Offer documentSEC
8-K/A · Current report, amendedJan 12, 2024Material contractSEC
PRE 14CJan 9, 2024Meeting noticeSEC
S-3 · Registration statementJan 4, 2024Offer documentSEC
10-K/A · Annual report, amendedJan 4, 2024Annual reportSEC
8-K · Current reportJan 2, 2024Material contractSEC
8-K · Current reportNov 29, 2023Management or board changeSEC
DEFR14ANov 16, 2023Meeting noticeSEC
10-Q · Quarterly reportNov 13, 2023Quarterly reportSEC
DEF 14A · Proxy statementNov 9, 2023Meeting noticeSEC
8-K · Current reportSep 5, 2023Material contractSEC
10-Q · Quarterly reportAug 10, 2023Quarterly reportSEC
8-K · Current reportJul 14, 2023Management or board changeSEC
8-K · Current reportJun 29, 2023Current reportSEC
8-K · Current reportJun 5, 2023Current reportSEC
8-K · Current reportMay 30, 2023Current reportSEC
10-Q · Quarterly reportMay 9, 2023Quarterly reportSEC
8-K · Current reportMay 4, 2023Management or board changeSEC
8-K · Current reportApr 6, 2023Material contractSEC
10-K · Annual reportMar 28, 2023Annual reportSEC
4 · Change in ownershipMar 21, 2023Insider tradeSEC
4 · Change in ownershipMar 21, 2023Insider tradeSEC
4 · Change in ownershipMar 21, 2023Insider tradeSEC
4 · Change in ownershipMar 21, 2023Insider tradeSEC
3 · Initial statement of ownershipFeb 6, 2023Insider tradeSEC
3 · Initial statement of ownershipFeb 6, 2023Insider tradeSEC
3 · Initial statement of ownershipFeb 6, 2023Insider tradeSEC
3 · Initial statement of ownershipFeb 6, 2023Insider tradeSEC
4 · Change in ownershipJan 30, 2023Insider tradeSEC
8-K · Current reportJan 27, 2023Management or board changeSEC
8-K · Current reportDec 30, 2022Current reportSEC
8-K · Current reportDec 23, 2022Management or board changeSEC
8-K · Current reportNov 21, 2022Meeting outcomeSEC
4/A · Change in ownership, amendedNov 14, 2022Insider tradeSEC
4 · Change in ownershipNov 14, 2022Insider tradeSEC
4 · Change in ownershipNov 14, 2022Insider tradeSEC
4 · Change in ownershipNov 14, 2022Insider tradeSEC
10-Q · Quarterly reportNov 10, 2022Quarterly reportSEC
ARS · Annual report to shareholdersOct 19, 2022Annual reportSEC
DEF 14A · Proxy statementOct 19, 2022Meeting noticeSEC
PRE 14A · Preliminary proxy statementOct 3, 2022Meeting noticeSEC
EFFECT · Notice that a registration is effectiveAug 23, 2022Other filingsSEC
4 · Change in ownershipAug 22, 2022Insider tradeSEC
4 · Change in ownershipAug 22, 2022Insider tradeSEC
4 · Change in ownershipAug 22, 2022Insider tradeSEC
CORRESP · Letter to the SECAug 18, 2022Other filingsSEC
S-1/A · Registration statement, amendedAug 18, 2022Offer documentSEC
S-1 · Registration statementAug 18, 2022Offer documentSEC
UPLOAD · Letter from the SECAug 15, 2022Other filingsSEC
DRS · Draft registration statementAug 9, 2022Offer documentSEC
10-Q · Quarterly reportAug 8, 2022Quarterly reportSEC
8-K · Current reportJul 13, 2022Material contractSEC
8-K · Current reportJun 10, 2022Current reportSEC
8-K · Current reportMay 27, 2022Management or board changeSEC
10-Q · Quarterly reportMay 16, 2022Quarterly reportSEC
8-K · Current reportApr 1, 2022Material contractSEC
3 · Initial statement of ownershipApr 1, 2022Insider tradeSEC
10-K · Annual reportMar 8, 2022Annual reportSEC
8-K/A · Current report, amendedFeb 23, 2022Current reportSEC
5 · Annual statement of ownershipFeb 14, 2022Insider tradeSEC

This page holds 200 of 264 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Healthcare Triangle, Inc.’s releases · as of Nov 11, 2026

Common shares
915,189
Fully diluted
37,105,674

Fully diluted

LineSharesAs of
Common shares915,189Nov 11, 2026
Warrants36,190,485Feb 28, 2025

Warrants and options

Lot
Warrants · US$0.84 · expiry not stated

Share count over time

CountShares
Nov 11, 2026915,189
Oct 22, 2026

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
UBS115K12.5%US$82,393Sep 30, 2026
Vanguard84,1219.2%US$60,399Sep 30, 2026
Geode Capital67,0607.3%US$48,122Sep 30, 2026
State Street37,3124.1%US$26,775Sep 30, 2026
BMO20,0002.2%US$14,352Sep 30, 2026
Tower Research Capital LLC (TRC)1,5650.17%US$1,123Sep 30, 2026
JPMorgan15<0.01%US$10Sep 30, 2026
Danske Bank A/S1<0.01%US$1Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Fidelity Extended Market Index Fund10,9051.2%US$28,135May 31, 2026
Invesco BuyBack AchieversTM ETF1,7110.19%US$1,882Jul 31, 2026
Fidelity Series Total Market Index Fund8590.09%US$2,216May 31, 2026
Vanguard Extended Market Index Fund8590.09%US$1,555Jun 30, 2026
Fidelity Total Market Index Fund1400.02%US$361May 31, 2026
Fidelity Nasdaq Composite Index Fund35<0.01%US$90May 31, 2026

Big stakes

StakeStakeSharesDateFiling
East West Capital, LLC9.90%821KFeb 27, 2025Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jeffrey S Mathiesen
Other companies: Solana Company (CFO and Treasurer, Director · Since at least Jun 10, 2020); NeuroOne Medical Technologies Corporation (Director · Since at least Aug 4, 2017); Panbela Therapeutics, Inc. (Director · Dec 1, 2020 – Mar 27, 2023 · Past); MetaVia Inc. (Chief Financial Officer · Aug 4, 2016 – Jan 28, 2018 · Past); Nuwellis, Inc. (Chief Financial Officer · Feb 14, 2012 – Jan 1, 2015 · Past); Zareba Systems Inc (Chief Financial Officer · Jun 30, 2008 – Jun 30, 2009 · Past)
Director · Mar 31, 2022 – Aug 19, 2022 · Past
Dave Rosa
Other companies: BioRestorative Therapies, Inc. (President & CEO at NeuroOne Medical Technologies Corp. (NASDAQ: NMTC) · Since at least Nov 4, 2021); NeuroOne Medical Technologies Corporation (CEO & President, Director · Since at least Jul 20, 2017); Biotricity, Inc. (Director · Jul 16, 2019 – Mar 12, 2023 · Past); Nuwellis, Inc. (Chief Executive Officer, Director · Feb 14, 2012 – Aug 1, 2015 · Past)
Director · Oct 15, 2021 – Mar 12, 2024 · Past
Ronald W McClurg
Other companies: Biotricity, Inc. (Director · May 4, 2022 – May 4, 2022 · Past); NeuroOne Medical Technologies Corporation (Chief Financial Officer · Jan 1, 2021 – Apr 17, 2025 · Past)
Director · Jan 27, 2023 – Mar 12, 2024 · Past
April BjornstadDirector · Oct 15, 2021 – Aug 19, 2022 · Past
Brendan GallagherDirector · Oct 15, 2021 – Dec 31, 2021 · Past
Lakshmanan KannappanBusiness Head · Mar 20, 2023 – Mar 31, 2025 · Past
Mogli SudishChief Technology Officer · Oct 15, 2021 – Dec 31, 2021 · Past
Mohammad Jainal BhuiyanDirector · Jan 27, 2023 – Mar 12, 2024 · Past
Paige HeaphyDirector · Jan 27, 2023 – Jan 27, 2023 · Past
Roy SookhooDirector · Jan 27, 2023 – Jan 27, 2023 · Past
All 14 people
PersonSeat
Shibu KizhakevilayilHead of M&A, Director · Oct 15, 2021 – Mar 31, 2025 · Past
Sumit GanguliChairman and Chief Executive Officer of Purpose Health, Inc · Jul 27, 2026 – Nov 5, 2026 · Past
Thyagarajan RamachandranChief Financial Officer · Oct 15, 2021 – Mar 31, 2025 · Past
Vivek PrakashDirector · Oct 15, 2021 – Dec 31, 2021 · Past

Open People

Log in to ask 6ix AI your own questions about Healthcare Triangle, Inc.